Catalog |
name |
Description |
price |
R-R-2930 |
Vericiguat CAS No.1350653-20-1 |
Vericiguat (BAY1021189)/CAS No.1350653-20-1 is a potent, orally available and soluble guanylate cyclase stimulator. |
price> |
R-R-2931 |
Linaclotide CAS No.851199-59-2 |
Linaclotide/CAS No.851199-59-2 is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation. |
price> |
R-R-2932 |
Cinaciguat CAS No.329773-35-5 |
Cinaciguat/CAS No.329773-35-5 is an activator of guanylate cyclase (sGC), and used for acute decompensated heart failure. |
price> |
R-R-2933 |
ODQ CAS No.41443-28-1 |
ODQ/CAS No.41443-28-1 is a potent and selective soluble guanylyl cyclase (sGC, nitric oxide-activated enzyme) inhibitor. ODQ enhances the pro-apoptotic effects of Cisplatin in human mesothelioma cells. |
price> |
R-R-2934 |
BAY 41-2272 CAS No.256376-24-6 |
BAY 41-2272/CAS No.256376-24-6 is an orally active and soluble guanylate cyclases (sGC) activator, which increases sGC activity by 400-fold in synergy with NO. BAY 41-2272 potently unloaded the heart, increased cardiac output, thus can be used for cardiovascular diseases research. |
price> |
R-R-2935 |
BAY 60-2770 CAS No.1027642-43-8 |
BAY 60-2770/CAS No.1027642-43-8 is a potent, selective, and orally active soluble guanylyl cyclase (sGC) activator. BAY 60-2770 increases the activity of sGC in a nitric oxide-independent manner. BAY 60-2770 shows antifibrotic effect. |
price> |
R-R-2936 |
Runcaciguat CAS No.1402936-61-1 |
Runcaciguat/CAS No.1402936-61-1 is an orally active stimulator of soluble guanylate cyclase, and is used in the research of cardiovascular and renal diseases combined with selective partial adenosine A1 receptor agonists. |
price> |
R-R-2937 |
NS-2028 CAS No.204326-43-2 |
NS-2028/CAS No.204326-43-2 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor with IC50 values of 30 nM and 200 nM for basal and NO-stimulated enzyme activity. NS-2028 inhibits soluble Guanylyl Cyclase activity in homogenates of mouse cerebellum and neuronal NO synthase with IC50 values of 17 nM and 20 nM. NS-2028 inhibits 3-morpholino-sydnonimine (SIN-1)-elicited formation of cyclic GMP in human cultured umbilical vein endothelial cells with an IC50 of 30 nM. NS-2028 is commonly used in the research of nitric oxide signaling pathways, it inhibits NO-dependent relaxant responses in non-vascular smooth muscle completely (1 μM). NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. |
price> |
R-R-2938 |
Ataciguat CAS No.254877-67-3 |
Ataciguat (HMR-1766)/CAS No.254877-67-3 is a nitric oxide-independent soluble guanylate cyclase (sGC) activator. Ataciguat is able to activate the ferric heme-iron redox form of sGC that stimulate the production of cyclic GMP (cGMP). Ataciguat exhibits vasodilator effects. |
price> |
R-R-2939 |
Cinaciguat hydrochloride CAS No.646995-35-9 |
Cinaciguat hydrochloride/CAS No.646995-35-9 is a potent soluble guanylate cyclase (GC) activator with EC50 of 15 nM in platelets. |
price> |